Agenda for first OncoProteomics World Congress Released
Select Biosciences are delighted to announce the inaugural World Congress dedicated to OncoProteomics will be held on the 27-28 April in South San Francisco. The top investigators applying proteomics to cancer research will be presenting their latest cutting edge work, providing a unique opportunity to delegates to network with the most senior researchers in the field.
Agenda sessions include:
- Alterations in the proteome in cancer
Keynote Speaker: Samir Hanash, Director, Fred Hutchinson Cancer Research Center
- Molecular diagnostics for cancer
Keynote Speaker: Gordon R. Whiteley, Director, Clinical Proteomics Reference Lab, NCI, Gaithersburg
- Protein biochips
Chaired by William E. Rich, CEO, Ciphergen
- Personalized therapies for cancer
Keynote Speaker: Jack A. Roth, Professor and Chairman, M. D. Anderson Cancer Center
For the full downloadable agenda (pdf) please visit www.OncoProteomicsCongress.com
Selected media partnerships are available for this event. For further information contact: Karen Saunders (ksaunders@selectbiosciences.com )
About Select Biosciences
Select Biosciences Ltd. is focused on organizing specialist biomedical meetings. Experts from both academia and commerce present timely information from current research through to commercial implementation of new technologies.
